Sight Sciences (SGHT) Invested Capital (2020 - 2026)

Sight Sciences' Invested Capital history runs 7 years deep, the most recent figure standing at $57.7 million for Q1 2026.

• In Q1 2026, Invested Capital fell 25.67% year-over-year to $57.7 million; the TTM figure through Mar 2026 stood at $57.7 million (down 25.67% YoY), while the FY2025 annual figure was $104.2 million, down 17.84% from the prior year.
• Invested Capital was $57.7 million for Q1 2026 at Sight Sciences, down from $104.2 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $211.9 million in Q1 2022 to a low of $57.7 million in Q1 2026.
• Historically, Invested Capital has averaged $125.9 million across 5 years, with a median of $126.9 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Invested Capital soared 310.23% in 2022, then tumbled 32.3% in 2025.
• A 5-year view of Invested Capital shows it stood at $193.4 million in 2022, then decreased by 20.29% to $154.1 million in 2023, then fell by 17.69% to $126.9 million in 2024, then slipped by 17.84% to $104.2 million in 2025, then slumped by 44.65% to $57.7 million in 2026.
• The last three Invested Capital figures came in at $57.7 million (Q1 2026), $104.2 million (Q4 2025), and $64.3 million (Q3 2025), per Business Quant data.